ARKF vs IBB
ARK Fintech Innovation ETF vs iShares Biotechnology ETF
ARKF—
ARK Fintech Innovation ETF
Fintech companies disrupting financial services.
Expense: —Yield: —
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKF | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKF top holdings
Holdings data unavailable for ARKF.
IBB top holdings
Holdings data unavailable for IBB.
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.